Akari Therapeutics Plc - ADR
NASDAQ:AKTX 3:59:56 PM EDT
Search For a Symbol
Akari Therapeutics Plc - ADR Stock, NASDAQ:AKTX
75/76 Wimpole Street, London, Greater London W1G 9RT
Number of Employees: 15
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.